GILD Price Profile

Open

$60.58

CLOSE

$60.74

DAY RANGE

60.31 - 61.18

52 WEEK RANGE

57.19 - 74.12

MARKET CAP

84.22B

Trading volume

8.16M

Prev. Close

61.18

50 Day MA

70.57

Shares Outstanding

1.25B

Public Float

1.25B

Average Volume

8.29M

Beta

0.36

PEG Ratio

6.35

Shares Shorted

21.3M

% OF SHARES SHORTED

1.70%

Short Ratio

2.91

1 Year Performance

5.13%

Diluted EPS (TTM)

5.84

Q Revenue Growth

0.13

Ebitda

14.93B

Gross Profit (TTM)

21B

Total Cash (MRQ)

6.61B

Total Debt (MRQ)

27.69B

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

Gilead Sciences (GILD) company profile

Gilead Sciences Inc. (NASDAQ: GILD) is a biopharmaceutical company that researches, develops, and commercializes medicines. The company focuses on advancing medicines to prevent and treat diseases like human immunodeficiency virus (HIV), viral hepatitis, and cancer. The company has existing collaboration with Arcus Biosciences, Pionyr; Tizona; Tango Therapeutics, Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S.

Latest GILD News

AD